Recent Release : Defense Industry Business Outlook and Procurement Report H1 2015
"Defense Industry Business Outlook and Procurement Report H1 2015" is a new report by Strategic Defence Intelligence that globally analyzes top priorities, key emerging and developed markets apart from merger and acquisition activity. In addition, it examines key procurement areas, future procurement budget and supplier prices outlook.Induction Furnace (IF) Market in India Will Grow at a CAGR of 6.24% During 2015-2019
About Induction FurnaceHelicopter Market in APAC to Grow at a CAGR of 15.74% over the Period 2015-2019
The civil helicopter market in Southeast Asia witnessed a growth rate of 8%. The market in Malaysia grew by 10% in 2014 because of its strong operational base, and offshore oil and gas exploration activities. Meanwhile, the markets in Indonesia, Myanmar, and Vietnam are also gaining momentum.Global PTCA Balloon Catheter Market to Grow at a CAGR of 3.48% During 2015-2019
A PTCA balloon catheter is a type of soft catheter equipped with a tiny inflatable balloon at its tip, which is inserted during a catheterization procedure into an artery that has been constricted by the addition of fatty deposits. The balloon is then bloated to clear the blockage and widen the artery. PTCA balloon catheters were the first devices used in the field of interventional cardiology. These catheters are also employed in the positioning of stents during angioplasty. PTCA balloon catheters are used in the PTCA procedures to compress the plaques within a blocked coronary artery.Global Blood Plasma Market Report: 2015 Edition - Research Background & Research Ideas
The raw material for blood plasma industry is the straw colored liquid that is a component of blood called blood plasma. It consists mostly of water and a small amount of proteins and antibodies. Those proteins are used to produce medicines, which are extracted to produce the end products for treatment that helps people with a variety of life-threatening diseases, illnesses and conditions. These plasma-derived medications are the standard course of treatment for thousands of people, in more than 100 countries across the globe, who need the treatment to improve their health and lead productive lives.